China Medical & HealthCare Group Ltd (0383:HK) Stock Forecast
Alert
Its only available to paid users.
N/A
Based on the China Medical & HealthCare Group Ltd stock forecast from 0 analysts, the average analyst target price for China Medical & HealthCare Group Ltd is not available over the next 12 months. China Medical & HealthCare Group Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of China Medical & HealthCare Group Ltd is Bearish, which is based on 3 positive signals and 8 negative signals. At the last closing, China Medical & HealthCare Group Ltd’s stock price was HKD 0.68. China Medical & HealthCare Group Ltd’s stock price has changed by +0.00% over the past week, +0.00% over the past month and -33.89% over the last year.
No recent analyst target price found for China Medical & HealthCare Group Ltd
No recent average analyst rating found for China Medical & HealthCare Group Ltd
Company Overview China Medical & HealthCare Group Ltd
China Medical & HealthCare Group Limited, an investment holding company, primarily operates hospitals in the People's Republic of China and Hong Kong. It operates through six segments: Healthcare, Eldercare, Property Development, Property Investment, Financial Services, and Securities Trading and Investments. The company also involved in property development of independent living units and project management of health campus with a focus on eldercare and retirement community including elderly nursing home, service apartments, independent living units and commercial area comprising shopping mall, retail shops, and club hall facilities. In addition, it develops and sells properties and lands; leases residential and office properties; and provides loan financial and healthcare services, as well as trading of securities listed in overseas exchange. The company was formerly known as COL Capital Limited and changed its name to China Medical & HealthCare Group Limited in February 2016. China Medical & HealthCare Group Limited was incorporated in 1989 and is headquartered in Wan Chai, Hong Kong. As of October 5, 2023, China Medical & HealthCare Group Limited operates as a subsidiary of Tian An China Investments Company Limited. Address: United Asia Finance Centre, Wan Chai, Hong Kong Read Less
China Medical & HealthCare Group Limited, an investment holding company, primarily operates hospitals in the People's Republic of China and Hong Kong. It operates through six segments: Healthcare, Eldercare, Property Development, Property Investment, Financial Services, and Secur...Read More
Frequently Asked Questions About China Medical & HealthCare Group Ltd (0383:HK) Stock
Stock Target Advisor's fundamental analysis for China Medical & HealthCare Group Ltd's stock is Bearish.
Unfortunately we do not have enough data on 0383:HK's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 0383:HK's stock to indicate what its average analyst target is.
0383:HK stock's Price/Earning ratio is 68.00.
Our analysis grades 0383:HK stock's Price / Earning ratio at F. This means that 0383:HK stock's Price/Earning ratio is above 81% of the stocks in the Medical Care Facilities sector in the HK exchange.
Based on this 0383:HK may be a overvalued for its sector.
The last closing price of 0383:HK's stock was HKD 0.68.
The most recent market capitalization for 0383:HK is HKD 0.74B.
Unfortunately we do not have enough analyst data on 0383:HK's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains China Medical & HealthCare Group Ltd's stock.
As per our most recent records China Medical & HealthCare Group Ltd has 2,599 Employees.
China Medical & HealthCare Group Ltd's registered address is China Online Centre, Wan Chai, Hong Kong.
You can get more information about it from China Medical & HealthCare Group Ltd's website at https://www.cmhg.com.hk.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
What not to like
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 0383:HK !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
